Cyclic GMP-dependent protein kinase inhibits osteopontin and thrombospondin production in rat aortic smooth muscle cells

Circulation Research

Volumn 82, Issue 2, 1998, Pages 139-146

  Dey, Nupur B ^b   Boerth, Nancy J ^b   Murphy Ullrich, Joanne E ^b   Chang, Pi Ling ^b   Prince, Charles W ^b   Lincoln, Thomas M ^a  

^a University of Alabama at Birmingham   (United States)

^b NONE

Author keywords

Atherosclerosis; Matrix protein vascular disease; Nitric oxide; Phenotype; Restenosis

Indexed keywords

CYCLIC GMP DEPENDENT PROTEIN KINASE; NITRIC OXIDE; OSTEOPONTIN; THROMBOSPONDIN;

ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; AORTA MEDIA; ARTERY INTIMA PROLIFERATION; ARTICLE; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS REGULATION; RAT; RESTENOSIS; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

EID: 0032498616     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.82.2.139     Document Type: Article

References (44)

1. Schwartz SM, O'Brien ER, deBlois D, Giachelli CM. Relevance of smooth muscle cell replication and development to vascular disease. In: Schwartz SM, Mecham RP, eds. The Vascular Smooth Muscle Cell. San Diego, Calif: Academic Press; 1995:81-139.
2. Ross R. Growth regulatory mechanisms and formation of the lesions of atherosclerosis. Ann N Y Acad Sci. 1995;748:1-4.
3. Mosse PR, Campbell GR, Wang ZL, Campbell JH. Smooth muscle phenotypic expression in human carotid arteries, I: comparison of cells from diffuse intimal thickenings adjacent to atheromatous plaques with those of the media. Lab Invest. 1985;53:556-562.
4. Fingerle J, Johnson R, Clowes AW, Majesky MW, Reidy MA. Role of platelets in smooth muscle cell proliferation and migration after vascular injury in rat carotid artery. Proc Nat Acad Sci U S A. 1989;86:8412-8416.
5. Schwartz SM, Heimark RL, Majesky MW. Developmental mechanisms underlying pathology of arteries. Physiol Rev. 1990;70:1177-1209.
6. Ferns GA, Stewart-Lee AL, Anggard EE. Arterial responses to mechanical injury: balloon catheter de-endothelialization. Atherosclerosis. 1992;92:89-104.
7. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
8. Glukhova MA, Kabakov AE, Frid MG, Ornasky OI, Belkin AM, Mukhin DN, Orekhov AN, Koteliansky VE, Smirnov VN. Modulation of human aorta smooth muscle cell phenotype: a study of muscle-specific variants of vinculin, caldesmon and actin expression. Proc Nat Acad Sci U S A. 1988;85:9542-9546.
9. Campbell JH, Campbell GR. Smooth muscle cell phenotype changes in arterial wall homeostasis: implication for the pathogenesis of atherosclerosis. Exp Mol Pathol. 1985;42:136-162.
10. Chamley-Campbell J, Campbell GR, Ross R. Phenotype-dependent response of cultured aortic smooth muscle cells to serum mitogens. J Cell BW. 1981;89:379-383.
11. Hedin U, Sjolund M, Hultgardh-Nilsson A, Thyberg J. Changes in expression and organization of smooth muscle-specific α-actin during fibronectin-mediated modulation of arterial smooth muscle cell phenotype. Differentiation. 1990;44:222-231.
12. Thyberg J, Hedin U, Sjolund M, Palmberg L, Bottger BA. Regulation of differentiated properties and proliferation of arterial smooth muscle cells. Arteriosclerosis. 1990;10:966-990.
13. Chamley-Campbell J, Campbell GR, Ross R. The smooth muscle cell in culture. Physiol Rev. 1979;59:1-61.
14. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest. 1989;83:1774-1777.
15. Kariya K, Kawahara Y, Araki S, Fukuzaki H, Takai Y. Antiproliferative action of cyclic GMP-elevating vasodilators in cultured rabbit aortic smooth muscle cells. Atherosclerosis. 1989;80:143-147.
16. Nakaki T, Nakayama M, Kato R. Inhibition by nitric oxide and nitric oxide-producing vasodilators of DNA synthesis in vascular smooth muscle cells. Eur J Pharmacol. 1990;189:347-353.
17. Cook JP, Singer AH, Tsao P, Zera P, Rowan RA, Billingham ME. Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest. 1992;90:1168-1172.
18. McNamara DB, Bedi B, Aurora H, Tena L, Ignarro LJ, Kadowitz PJ, Akers DL. L-Arginine inhibits balloon catheter-induced intimal hyperplasia. Biochem Biophys Res Commun. 1993;193:291-296.
19. Davies MJ, Kim JH, Dalen H, Makhoul RG, Svendsen E, Hagen PO. Reduction of experimental vein graft intimal hyperplasia and preservation of nitric oxide-mediated relaxation by the nitric oxide precursor L-arginine. Surgery. 1994;116:557-568.
20. Cayatte AJ, Palacino JJ, Horten K, Cohen RA. Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler Thromb. 1994;14:753-759.
21. Ignarro LJ, Kadowitz P. The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation. Annu Rev Pharmacol Toxicol. 1985;25:171-191.
22. Furchgott RF. Studies on relaxation of rabbit aorta by sodium nitrate: the basis for the proposal that the acid-activatable inhibitory factor from bovine retractor penis is inorganic nitrate and the endothelium-derived relaxing factor is nitric oxide. In: Vanhoutte P, ed. Mechanisms of Vasodilation. New York, NY: Raven Press Publishers; 1988;4:401-414.
23. Lincoln TM, Cornwell TL, Komalavilas P, MacMillan-Crow LA, Boerth NJ. The nitric oxide-cyclic GMP signaling system. In: Barany M, ed. Biochemistry of Smooth Muscle Contraction. San Diego, Calif: Academic Press; 1996:257-268.
24. Boerth NJ, Dey N, Cornwell TL, Lincoln TM. Cyclic GMP-dependent protein kinase regulates vascular smooth muscle cell phenotype. J Vasc Res. 1997;34:245-259.
25. Giachelli CM, Bae N, Almeida M, Denhardt DT, Alpers CE, Schwartz SM. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest. 1993;92:1686-1696.
26. Shanahan CM, Weissberg PL, Metcalfe JC. Isolation of gene markers of differentiated and proliferating vascular smooth muscle cells. Circ Res. 1993;73:193-204.
27. Gadeau A-P, Campan M, Millet D, Candresse T, Desgranges C. Osteopontin overexpression is associated with arterial smooth muscle cell proliferation in vitro. Arterioscler Thromb. 1993;13:120-125.
28. Wang X, Louden C, Ohlstein EH, Stadel JM, Gu JL, Vue TL-. Osteopontin expression in platelet-derived growth factor-stimulated vascular smooth muscle cells and carotid artery after balloon angioplasty. Arterioscler Thromb Vasc Biol. 1996;16:1365-1372.
29. Majack RA, Milbrandt J, Dixit VM. Induction of thrombospondin messenger RNA levels occurs as an immediate early response to platelet-derived growth factor. J Biol Chem. 1987;262:8821-8825.
30. Majesky MW. Neointima formation after acute vascular injury: role of counter-adhesive extracellular matrix proteins. Tex Heart Inst J. 1994;21:78-85.
31. 2+ by atriopeptin and 8-bromo-cyclic GMP is mediated by cyclic GMP-dependent protein kinase. J Biol Chem. 1989;264:1146-1155.
32. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
33. Wernet W, Flockerzi V, Hofmann F. The cDNAs of the two isoforms of bovine cGMP-dependent protein kinase. FEBS Lett. 1989;251:191-196.
34. Boerth NJ, Lincoln TM. Expression of the catalytic domain of cyclic GMP-dependent protein kinase in a baculovirus system. FEBS Lett. 1994;342:255-260.
35. Lawler J, Hynes RO. The structure of human thrombospondin, an adhesive glycoprotein with multiple calcium binding sites and homologies with several different proteins. J Cell Biol. 1986;103:1635-1648.
36. Schultz-Cherry S, Murphy-Ullrich JE. Thrombospondin causes activation of latent transforming growth factor-β secreted by endothelial cells by a novel mechanism. J Cell Biol. 1993;122:923-932.
37. Cornwell TL, Soff GA, Traynor AE, Lincoln TM. Regulation of the expression of cyclic GMP-dependent protein kinase by cell density in vascular smooth muscle cells. J Vasc Res. 1994;31:330-337.
38. Cornwell TL, Arnold E, Boerth NJ, Lincoln TM. Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP. Am J Physiol. 1994;267:C1405-C1413.
39. Anderson PG, Williams EL, Cornwell TL, Lincoln TM. Cyclic GMP-dependent protein kinase in injured human and pig coronary arteries. J Vasc Res. 1996;33(suppl 1):9. Abstract.
40. Liaw L, Almeida M, Hart CE, Schwartz SM, Giachelli CM. Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro. Circ Res. 1994;74:214-224.
41. Gordon D, Reidy MA, Benditt EP, Schwartz SM. Cell proliferation in human coronary arteries. Pror Nat Acad Sci U S A. 1990;87:4600-4604.
42. Katsuda S, Coltrera MD, Ross R, Gown AM. Human atherosclerosis, IV: immunocytochemical analysis of cell activation and proliferation in lesions of young adults. Am J Pathol. 1993;142:1787-1793.
43. Dubey RK, Jackson EK, Luscher TF. Nitric oxide inhibits angiotensin II-mediated migration of rat aortic smooth muscle cells. J Clin Invest. 1995;96:141-149.
44. Sarkar R, Meinberg EG, Stanley JC, Gordon D, Webb RC. Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells. Circ Res. 1996;78:225-230.